Advertisement
Advertisement

RZLT

RZLT logo

Rezolute Inc

4.19
USD
-0.25
-5.63%
Dec 18, 15:02 UTC -5
Open

Rezolute Inc Profile

About

Rezolute, Inc. is a biopharmaceutical company specializing in the development of drug therapies for metabolic and orphan diseases. The Company's products include AB101, RZ358, RZ402 and RZ602 which are in clinical stage. Rezolute, Inc., formerly known as AntriaBio, Inc., is based in LOUISVILLE, United States.

Info & Links

CEO

Nevan Charles Elam

Headquarters

275 SHORELINE DRIVE, SUITE 500
REDWOOD CITY, CA 94065, UNITED STATES

Industry

Pharmaceuticals Major

Sector

Health Technology

Website

www.rezolutebio.com

Auditor

GRANT THORNTON LLP

Share holders

261

Employees

59

Rezolute Inc Statistics

Valuation Measures

Market Capitalization2

242.77M

Enterprise Value

232.30M

Enterprise Value/EBITDA(ttm)

-3.05

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

2.26

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-69.83%

Return on Invested Capital(ttm)

-71.77%

Return on Assets(ttm)

-62.16%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-76.06M

Net Income Available to Common(ttm)

-69.31M

Diluted EPS(ttm)

-1.27

Share Statistics

Beta (5Y Monthly)

1.01

52-Week Change

420.46%

S&P 500 52-Week Change

26.31%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

57.94M

Dividend Yield

0.00%

Float4

47.29M

% Held by Insiders

18.39%

% Held by Institutions

82.97%

Balance Sheet

Total Cash(mrq)

108.27M

Total Cash Per Share(mrq)

1.87

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

13.79%

Quick Ratio(mrq)

13.79%

Book Value Per Share(mrq)

2.05

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.23

Free Cash Flow(ytd)

-16.01M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement